Codexis has been granted a US patent covering biocatalytic processes for the preparation of fused bicyclic proline compounds. These compounds are used to make key intermediates in the synthesis of leading hepatitis-C therapeutics.
Codexis
Wednesday, 16 May 2012
Codexis granted patent
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment